Compound Interest
COVID has generated unprecedented levels of interest in antiviral medicines, but they’re just the latest in a long line of antivirals going back almost 70 years. The latest edition of Periodic Graphics in Chemical & Engineering News looks at some of the key drugs, from the first antiviral to be approved to antivirals for HIV […]
In 2020, science news was dominated by COVID and vaccine development. In many ways, 2021 has been little different, but away from the virus we’re now overly familiar with there were plenty of other chemistry-related news stories. This graphic highlights a selection of them – see below for more details as well as links to […]
On this day a year ago, the Alpha variant of the SARS-CoV-2 virus was designated a variant of concern. The final graphic in the #ChemVsCOVID series with the Royal Society of Chemistry looks at how variants are tracked and what causes the differences between them.
On this day a year ago, the UK started its piloting of mass testing in the city of Liverpool using lateral flow tests. The latest graphic in the #ChemVsCOVID series with the Royal Society of Chemistry looks at how these tests work, and how accurate are they compared to the standard PCR tests that are […]
One year ago, in October 2020, the US FDA approved remdesivir: the first antiviral drug approved for COVID-19. While it’s not as effective as was first thought, similar drugs look like they could be more successful. The latest graphic in the #ChemVsCOVID series with the Royal Society of Chemistry examines how they work.
How does COVID spread? Of all the questions about the pandemic, this seems like it would be a fairly simple one to answer. But, even several months into the pandemic, the guidance from public health organisations did not recognise the potential for COVID to be transmitted through the air. The latest edition of the Chem […]